The University of Chicago Header Logo

Connection

Julie Fitzgerald to Biomarkers

This is a "connection" page, showing publications Julie Fitzgerald has written about Biomarkers.
Connection Strength

1.231
  1. Renal Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Pediatrics. 2022 01 01; 149(1 Suppl 1):S66-S73.
    View in: PubMed
    Score: 0.132
  2. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Sci Transl Med. 2019 11 13; 11(518).
    View in: PubMed
    Score: 0.114
  3. Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury. Antimicrob Agents Chemother. 2019 07; 63(7).
    View in: PubMed
    Score: 0.111
  4. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia. Cancer Discov. 2016 06; 6(6):664-79.
    View in: PubMed
    Score: 0.089
  5. Prospective Testing and Redesign of a Temporal Biomarker Based Risk Model for Patients With Septic Shock: Implications for Septic Shock Biology. EBioMedicine. 2015 Dec; 2(12):2087-93.
    View in: PubMed
    Score: 0.087
  6. The temporal version of the pediatric sepsis biomarker risk model. PLoS One. 2014; 9(3):e92121.
    View in: PubMed
    Score: 0.077
  7. SERUM HUMANIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE-ORGAN DYSFUNCTION SYNDROME. Shock. 2024 Jan 01; 61(1):83-88.
    View in: PubMed
    Score: 0.038
  8. Unmasking Critical Illness: Using Machine Learning and Biomarkers to See What Lies Beneath. Pediatr Crit Care Med. 2023 10; 24(10):869-871.
    View in: PubMed
    Score: 0.037
  9. SERUM SOLUBLE ENDOGLIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE ORGAN DYSFUNCTION SYNDROME. Shock. 2023 09 01; 60(3):379-384.
    View in: PubMed
    Score: 0.037
  10. Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury: risk-stratified analysis from a prospective observational cohort of pediatric septic shock. Crit Care. 2023 07 03; 27(1):260.
    View in: PubMed
    Score: 0.037
  11. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1. Crit Care. 2023 06 26; 27(1):250.
    View in: PubMed
    Score: 0.037
  12. Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective observational study. Crit Care. 2022 07 11; 26(1):210.
    View in: PubMed
    Score: 0.034
  13. Temperature Trajectory Sub-phenotypes and the Immuno-Inflammatory Response in Pediatric Sepsis. Shock. 2022 05 01; 57(5):645-651.
    View in: PubMed
    Score: 0.033
  14. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021 03 16; 325(11):1074-1087.
    View in: PubMed
    Score: 0.031
  15. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020 12 08; 4(23):6051-6063.
    View in: PubMed
    Score: 0.031
  16. Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock. Crit Care Med. 2020 10; 48(10):1513-1520.
    View in: PubMed
    Score: 0.030
  17. Utility of Procalcitonin as a Biomarker for Sepsis in Children. J Clin Microbiol. 2020 06 24; 58(7).
    View in: PubMed
    Score: 0.030
  18. PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock. Am J Respir Crit Care Med. 2020 04 01; 201(7):848-855.
    View in: PubMed
    Score: 0.029
  19. Derivation of a metabolic signature associated with bacterial meningitis in infants. Pediatr Res. 2020 08; 88(2):184-191.
    View in: PubMed
    Score: 0.029
  20. Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study. J Pediatric Infect Dis Soc. 2020 Feb 28; 9(1):36-43.
    View in: PubMed
    Score: 0.029
  21. Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP. Am J Respir Crit Care Med. 2017 08 15; 196(4):494-501.
    View in: PubMed
    Score: 0.024
  22. A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):134-141.
    View in: PubMed
    Score: 0.024
  23. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017 06; 45(6):1061-1093.
    View in: PubMed
    Score: 0.024
  24. Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype. Crit Care Med. 2016 Nov; 44(11):2010-2017.
    View in: PubMed
    Score: 0.023
  25. Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids. Crit Care Med. 2016 10; 44(10):e1000-3.
    View in: PubMed
    Score: 0.023
  26. A Multibiomarker-Based Model for Estimating the Risk of Septic Acute Kidney Injury. Crit Care Med. 2015 Aug; 43(8):1646-53.
    View in: PubMed
    Score: 0.021
  27. Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One. 2014; 9(1):e86242.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.